Xtalks

📬 Stay ahead with expert insights, job opportunities, and must-attend life science webinars in the November 2024 edition of the Xtalks Community Connection newsletter! 🌟 This month, we’re covering key topics in clinical trials, drug development, and pharma manufacturing. Hear experts discuss current industry challenges and explore the impact of digitized protocols, and catch our top 10 pharma/biotech layoffs of 2024 — all this and more below ⬇️

With significant reductions in cataplexy attacks, enhanced cognition and long-term safety demonstrated in the ENCORE Phase III trial, Axsome Therapeutics’ AXS-12 (reboxetine) brings immense potential. Read more at https://buff.ly/4g9S6ys by Soumya Shashikumar.

This #WorldAIDSDay2024, delve into inspiring stories of HIV remission, two-drug regimens and community-led campaigns advancing treatment and prevention. Learn how science and rights-based approaches converge to end HIV by Soumya Shashikumar at https://buff.ly/4ePhPLK.

In this episode, hear about the work Dr. Thomas Heineman is leading at Oncolytics Biotech Inc. in the development of oncolytic virus therapy. Listen now at https://buff.ly/3AS12tz 🎙️

How does apheresis shape the future of cellular therapies? Join Comprehensive Cell Solutions (CCS) for a webinar exploring the pivotal role of apheresis in sourcing high-quality starting materials for treatments like CAR T-cell therapies and stem cell transplants. Discover how hospitals can enhance their programs, elevate patient care, and improve therapy success rates through optimized apheresis procedures. Register now to explore the intersection of quality and innovation in regenerative medicine: https://buff.ly/3CMh7Bz

How can beverage brands stand out in a competitive market? Join Brenntag to explore how trends like sugar reduction, functional ingredients, and clean-label solutions are driving innovation in the beverage industry. Learn how products like prebiotics, natural sweeteners, and natural colors can meet consumer expectations and add value. 📥 Register now to stay ahead in beverage innovation: https://buff.ly/3VdaZst #BeverageInnovation #CleanLabel #FNB

How can clinical trials ensure data integrity and participant safety in the face of growing duplicate enrollments? Our upcoming webinar with Fortrea explores the rise of “professional participants,” their impact on study outcomes, and the risks they pose to themselves and trials. Discover proactive strategies, from Quality by Design initiatives to advanced technologies, that help identify duplicates and enhance patient safety. Register now to gain insights into safeguarding the future of clinical trials: https://buff.ly/4g4pkzb

Diversity in clinical trials is no longer a luxury — it’s a necessity. In this Xtalks Spotlight, Ryan B. from H1 discusses how a data-driven, inclusive approach is crucial for developing treatments that truly reflect the needs of all populations. Ryan highlights the key challenges in achieving diversity in clinical trials, from misalignment within organizations to financial constraints at recruitment sites. She also reveals how addressing the awareness gap among patients can unlock broader participation and make trials more inclusive. Read more here: https://buff.ly/3YYfjNi #ClinicalResearch #InclusiveDesign #TrialDiversity

BridgeBio’s Attruby (acoramidis) is now FDA-approved to treat transthyretin amyloid cardiomyopathy (ATTR-CM). Learn more about this next-generation therapy that reduces mortality and hospitalizations at https://buff.ly/495qisR by Soumya Shashikumar.